Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

That includes the MiniMed 780G automated insulin delivery (AID) system, cleared by the U.S. Food and Drug Administration (FDA) in 2023. This helped the Diabetes segment's organic sales increase by ...

Revenues in the Diabetes group rose 12.6% organically to $647 million. U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated insulin delivery system.

As chronic illnesses rise and technology leaps forward, the demand for cutting-edge medical devices intensifies. Medtronic ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article. This, combined with competition from pod-based insulin delivery with no pumps or ...

A.L.P. has been a consultant for Medtronic MiniMed and has received a grant from the Medtronic/MiniMed Foundation. She has served as a consultant and/or speaker for multiple nondevice-related ...

U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated insulin delivery system. International revenues grew by low double digits on increasing CGM attachment ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

Moreover, I've completed a comparative analysis of the system relative to Medtronic's (MDT) MiniMed system and Tandem Diabetes (TNDM) tX2 with the control-IQ technology (Figure 3). The question is ...

The headline numbers from Medtronic highlight a solid start to its fiscal 2025. For the company's first quarter, adjusted ...